TickerFactsScreenerDevelopers

Beam Therapeutics Inc. (BEAM) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2019: $37.22M2020: $162.17M2021: $559.99M2022: $232.77M2023: $435.89M2024: $281.97M2025: $294.94M$294.94M
2019Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$294.94M+4.6%
2024$281.97M-35.3%
2023$435.89M+87.3%
2022$232.77M-58.4%
2021$559.99M+245.3%
2020$162.17M+335.7%
2019$37.22M—